Practical Management of the Wolff-Parkinson-White Syndrome

  • Edward L. C. Pritchett


The Wolff-Parkinson-White (WPW) syndrome is the arrhythmia syndrome that is understood best. It holds a special fascination for cardiologists interested in patients with arrhythmias. Speculation and deduction by electrocardiographers about the mechanisms of tachycardia in these patients have largely been confirmed by elegant studies done during the past 15 years using intracardiac recording and programmed stimulation with electrode catheters [1,2]. Intraoperative mapping of epicardial activation and successful operative treatment of these patients have further enhanced our understanding of this interesting syndrome [3,4].


Atrial Fibrillation Ventricular Fibrillation Normal Sinus Rhythm Delta Wave Quinidine Sulfate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Scherlag BJ, Lau SH, Helfant RM, Stein E, Berkowitz WD, Damato AN: Catheter technique for recording His bundle activity in man. Circulation 39: 13, 1969.PubMedGoogle Scholar
  2. 2.
    Durrer D, Schoo L, Schuilenburg RM, Wellens HJJ: The role of premature beats in the initiation and termination of supravenatricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation 36: 644, 1967.PubMedGoogle Scholar
  3. 3.
    Cobb FR, Blumenschein SD, Sealy WC, Boineau JP, Wagner GS, Wallace AG: Successful surgical interruption of the bundle of Kent in a patient with Wolff-Parkinson-White syndrome. Circulation 38: 1018, 1968.PubMedGoogle Scholar
  4. 4.
    Pritchett ELC, Gallagher JJ, Sealy WC, Anderson R, Campbell RWF, Seller TD, Jr, Wallace AG: Supraventricular tachycardia dependent upon accessory pathways in the absence of ven¬tricular preexcitation. Am. J. Med. 61: 214, 1978.CrossRefGoogle Scholar
  5. 5.
    Pritchett ELC: Office Management of Arrhyth¬mias, Saunders, Philadelphia, 162 pages, 1982.Google Scholar
  6. 6.
    Pritchett ELC, Zimmerman JM, Hammill KF, Reiter MJ, Hammill SC: Electrocardiogram recording by telephone in antiarrhythmic drug trials. Chest 81: 473, 1982.PubMedCrossRefGoogle Scholar
  7. 7.
    Klein GJ, Bashore TM, Sellers TD, Pritchett ELC, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. N. Engl. J. Med. 30: 1081, 1979.Google Scholar
  8. 8.
    Campbell RWF, Smith RA, Gallagher JJ, Pritchett ELC, Wallace AG: Atrial fibrillation in the preexcitation syndrome. Am. J. Cardiol. 40: 514, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Bauerfeind RA, Wyndham CR, Swiryn SP, Palileo E, Strasberg B, Lam W, Westveer D, Rosen KM: Paroxysmal atrial fibrillation in the Wolff-Parkinson-White syndrome. Am. J. Car¬diol. 47: 562, 1981.CrossRefGoogle Scholar
  10. 10.
    Roark SF, McCarthy EA, Lee KL, Pritchett ELC: The incidence of atrial fibrillation in patients with paroxysmal atrial tachycardia. Circulation. (in. press).Google Scholar
  11. 11.
    Hammill SC, Pritchett ELC, Klein GJ, Smith WM, Gallagher JJ: Accessory atrioventricular pathways that conduct only in the antegrade direction. Circulation 62: 1335, 1980.PubMedGoogle Scholar
  12. 12.
    Klein GJ, Yee R, Sharma AD: Concealed conduction in accessory pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome. Circulation 70: 402, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Klein GJ, Gulamhusein SS: Intermittent pre-excitation in the Wolff-Parkinson-White syn¬drome. Am. J. Cardiol. 52: 292, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Wellens HJJ, Braat S, Brugada P, Gorgels APM, Bar FW: Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathway. Am. J. Cardiol. 50: 1087, 1982.PubMedCrossRefGoogle Scholar
  15. 15.
    Sellers TD Jr, Campbell RWF, Bashore TM: Effects of procainamide and quinidine sulfate in the Wolff-Parkinson-White syndrome. Circulation 55: 15, 1977.PubMedGoogle Scholar
  16. 16.
    Kerr CR, Prystowsky EN, Smith WM, Cook L, Gallagher JJ: Electrophysiological effects of diso¬pyramide phosphate in patients with Wolff¬Parkinson-White syndrome. Circulation 65: 869, 1982.PubMedCrossRefGoogle Scholar
  17. 17.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RAJ, Camm AJ: Cardiac electrophys¬iologic effects of flecainide acetate for paroxys¬mal reentrant junctional tachycardias. Am. J. Cardiol. 51: 770, 1983.PubMedCrossRefGoogle Scholar
  18. 18.
    Neuss H, Buss J, Schlepper M, Berthold R, Mitrovic V, Kramer A, Musical WJ: Effects of flecainide on electrophysiological properties of accessory pathways in the Wolff-Parkinson¬White syndrome. Eur. Heart J. 4: 347, 1983.PubMedGoogle Scholar
  19. 19.
    Rosenbaum MB, Chiale PA, Ryba D, Elizari MV: Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am. J. Cardiol. 34: 215, 1974.PubMedCrossRefGoogle Scholar
  20. 20.
    Ward DE, Camm AJ, Spurrell RAJ: Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias. Br. Heart J. 44: 91, 1980.PubMedCrossRefGoogle Scholar
  21. 21.
    Mauritson DR, Winniford MD, Walker WS, Rude RE, Cory JR, Hillis LD: Oral verapamil for paroxysmal supraventricular tachycardia. A long-term, double-blind randomized trial. Ann. Intern. Med. 96: 409, 1982.PubMedGoogle Scholar
  22. 22.
    Pritchett ELC, Hammill SC, Reiter MJ, Lee KL, McCarthy EA, Zimmerman JM, Shand DG: Life table methods for evaluating antiarrhythmic drug efficacy in patients with paroxysmal atrial tachycardia. Am. J. Cardiol. 52: 1007, 1983.PubMedCrossRefGoogle Scholar
  23. 23.
    Waxman HL, Myerburg RJ, Appel R, Sung RJ: Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation and flutter. Ann. Intern. Med. 94: 1, 1981.PubMedGoogle Scholar
  24. 24.
    Bardy GH, Packer DL, German LD, Gallagher JJ: Preexcited reciprocating tachycardia in patients with Wolff-Parkinson-White syndrome: incidence and mechanisms. Circulation 70: 377, 1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Benditt DG, Pritchett ELC, Gallagher JJ: Spectrum of regular tachycardias with wide QRS complexes in patients with accessory atrioventricular pathways. Am. J. Cardiol. 42: 828, 1978.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing 1986

Authors and Affiliations

  • Edward L. C. Pritchett

There are no affiliations available

Personalised recommendations